Lélia Delamarre - Senior Scientist, Cancer Immunology

Lélia Delamarre

Senior Scientist, Cancer Immunology

"Genentech provides scientists with the unique opportunity to do ground-breaking science with the goal of developing innovative therapies for patients."
12
Years at Genentech
16
Publications

I joined Genentech in 2007 after my postdoctoral training at Yale University where I studied the cellular mechanisms underlying the unique capacity of dendritic cells to capture and present antigens for T cell priming. At Genentech in the Cancer Immunology Department, I have been pursuing my research interests with the goal of developing novel approaches to expand effective T cell responses to cancer through priming. I feel extremely fortunate to be surrounded by colleagues with various scientific background who are highly enthusiastic, engaged, and eager to collaborate. They inspire me to give my best.

Featured Publication